´
´
´
´
M. Avalos, R. Babiano, P. Cintas, J. Dıaz, J. L. Jimenez, I. Lopez, J. C. Palacios
FULL PAPER
2.05 (m, 2 H, JCH3ϪCH2 ϭ 7.5, JCH2ϪCH ϭ 14.9 Hz, CH3CH2), 0.97
ArCH3, 12a, cis-12b, trans-12b), 14.4, 14.2, 13.8 (ArCH2CH3, 12a,
(t, J ϭ 7.4 Hz, 3 H, CH3CH2) ppm. 13C NMR (100 MHz, CDCl3): cis-12b, trans-12b) ppm. C19H19NOS (309.12): calcd. C 73.75, H
δ ϭ 171.4 (C-4), 137.7, 135.9, 134.2, 129.6, 128.9, 128.8, 128.3,
128.1 (ArC, ArN, C2), 104.4 (C-2ϭCH), 51.0 (C-5), 21.2
(CH2CH3), 14.1 (CH2CH3) ppm. C18H17NOS (295.10): calcd. C
73.19, H 5.80, N 4.74, S 10.86; found C 72.70, H 5.94, N 4.72, S
10.97. A solution of 10b in CDCl3, if left at room temp. for several
6.19, N 4.53, S 10.36; found C 73.62, H 6.30, N 4.23, S 10.52.
General Procedure for the Preparation of N-Thioformyl-N-acetanil-
ides 16؊17:
A solution of 2-chloro-2-phenylacetyl chloride
(6.61 mmol) in CH2Cl2 (5 mL) was added dropwise, with magnetic
stirring, to a solution of thioformamide 13 or 14 (6.61 mmol) in
CH2Cl2 (20 mL), followed after 25 min by a second solution of
Et3N (13.2 mmol) in CH2Cl2 (5 mL). The organic layer was washed
repeatedly with brine, dried (MgSO4), and concentrated to a quar-
ter of its initial volume.
1
days, evolved into a mixture of 10a and 10b (1:1 ratio). H NMR
(400 MHz, CDCl3): δ ϭ 7.51Ϫ7.25 (m, 10 H, ArH, 10a), 2.60 (t,
J ϭ 7.38 Hz, 2 H, CH3CH2CH2, 10a), 1.70 (m, 2 H, JCH3ϪCH2
ϭ
7.4, JCH2ϪCH2 ϭ 7.5 Hz, CH3CH2CH2, 10a), 0.97 (t, J ϭ 7.5 Hz,
3 H, CH3CH2CH2, 10a) ppm.
N-[Chloro(phenyl)acetyl]-N-thioformyl-2,6-dimethylaniline
(16):
3-(2,6-Dimethylphenyl)-2-methyl-5-phenyl-1,3-thiazolium-4-olate
(11a) and 3-(2,6-Dimethylphenyl)-2-methylidene-5-phenyl-1,3-thia-
zolidin-4-one (11b): Application of the general procedure to thioam-
ide 6 gave a solution. This was concentrated, and the residue was
crystallized from diethyl ether (3.8 mmol, 58%); m.p. 122 °C (dec.).
Starting from 13, the CH2Cl2 solution was diluted with diethyl
ether and petroleum ether until incipient precipitation. The re-
sulting suspension was kept at Ϫ20 °C, and crystallized on standing
(3.3 mmol, 50%); m.p. 143 °C. IR (KBr): ν˜max. ϭ 1724 cmϪ1 1H
.
NMR (400 MHz, CDCl3): δ ϭ 10.86 (s, 1 H, CSH), 7.37Ϫ7.02 (m,
10 H, ArH), 5.19 (s, 1 H, CH), 2.23 (s, 3 H, ArCH3), 1.34 (s, 3 H,
ArCH3) ppm. 13C NMR (100 MHz, CDCl3): δ ϭ 194.1 (CS), 167.4
(CO), 137.4, 135.8, 134.4, 133.5, 130.3, 130.0, 129.3, 129.0, 128.7
(ArC, ArN), 57.9 (CH), 17.9 16.9 (ArCH3) ppm. C17H16NOSCl
(317.06): calcd. C 64.24, H 5.07, N 4.41, S 10.09; found C 63.78,
H 5.06, N 4.04, S 11.04. HRMS (IQϩ): calcd. for C17H16ClNOS
317.06411; found 317.06660; ∆ ϭ 4.6 ppm. HRMS (BARϩ): calcd.
for C17H16ClNOS ϩ Hϩ 317.07194; found 318.071839; ∆ ϭ
0.3 ppm.
IR (KBr): ν˜max ϭ 1697, 1646, 1596 cmϪ1 1H NMR (400 MHz,
.
CDCl3): δ ϭ 7.91 (d, J ϭ 7.6 Hz, 1 H, ArH, 11a), 7.53Ϫ7.11 (m,
ArH, 9 H of 11a and 10 H of 11b), 5.26 (s, 1 H, CH, 11b), 4.32 (d,
J ϭ 2.8 Hz, 1 H, C-2ϭCH2, 11b), 4.05 (d, J ϭ 2.8 Hz, 1 H, C-2ϭ
CH2, 11b), 2.34 (s, 1 H, CH3, 11a), 2.18, 2.12 (s, 6 H, ArCH3, 11b),
2.10 (s, 6 H, ArCH3, 11a) ppm. 13C NMR (100 MHz, CDCl3): δ ϭ
170.7 (C-4, 11b), 158.9 (C-4, 11a), 139.0, 137.1, 136.6, 136.4, 135.1,
133.8, 133.0, 129.9, 129.3, 128.9, 128.8, 128.7, 128.6, 128.5, 128.3,
124.5, 123.4, 85.1 (C-2ϭCH2, 11b), 51.5 (C-5, 11b), 17.6, 17.4
(CH3Ar, 11a, 11b), 16.8 (C-2ϪCH3, 11a) ppm. C18H17NOS
(295.10): calcd. C 73.19, H 5.80, N 4.74, S 10.86; found C 72.66,
H 6.07, N 4.549, S 11.11. HRMS (CIϩ): calcd. for C18H17NOS
295.10308; found 295.102895; ∆ ϭ 0.6 ppm. HRMS (FABϩ): calcd.
for C18H17NOSHϩ 296.11091; found 296.111390; ∆ ϭ Ϫ1.6 ppm.
The above mixture of tautomers 11a and 11b was dissolved in
CH2Cl2, diluted with diethyl ether until precipitation, and kept at
N-[Chloro(phenyl)acetyl]-2-ethyl-6-methyl-N-thioformylaniline (17):
Starting from 14, the CH2Cl2 solution was diluted with diethyl
ether and petroleum ether until incipient precipitation. The re-
sulting suspension was kept at Ϫ20 °C, and an orange solid crys-
tallized (2.4 mmol, 36%); m.p. 140.5 °C. IR (KBr): ν˜max ϭ 2945,
1785 cmϪ1. 1H NMR (400 MHz, CDCl3): δ ϭ 10.89 (s, 1 H, CSH,
17b), 10.88 (s, 1 H, CSH, 17a), 7.42Ϫ7.02 (m, 10 H, ArH, 17a,
17b), 5.20 (s, 1 H, CH, 17a), 5.16 (s, 1 H, CH, 17b), 2.60Ϫ2.46 (m,
J ϭ 7.7 Hz, 2 H, ArCH3CH2, 17a, 17b), 2.24 (s, 3 H, ArCH3, 17a),
2.16 (s, 3 H, ArCH3, 17b), 1.26 (t, J ϭ 7.4 Hz, 3 H, ArCH3CH2,
17a), 0.79 (t, J ϭ 7.4 Hz, 3 H, ArCH3CH2, 17b) ppm. 13C NMR
(100 MHz, CDCl3): δ ϭ 194.5 (CSH, 17a, 17b), 167.5 (CO, 17a,
17b), 142.1, 141.1, 137.2, 133.8, 133.4, 130.4, 130.0, 129.1, 129.0,
128.7, 127.0, 126.6 (ArC, ArN, 17a, 17b), 58.0 (CH, 17a), 57.6 (CH,
17b), 23.7 (ArCH2CH3, 17a), 22.6 (ArCH2CH3, 17b), 17.9
(ArCH2CH3, 17b), 16.9 (ArCH2CH3, 17a), 13.9 (ArCH3, 17a), 12.9
(ArCH3, 17b) ppm. C18H18NOSCl (331.08): calcd. C 65.15, H 5.47,
N 4.22, S 9.66; found C 64.80, H 5.57, N 4.61, S 9.42. HRMS
Ϫ20 °C. Tautomer 11b crystallized on standing. IR (KBr): ν˜max
ϭ
1695, 1595 cmϪ1
.
3-(2-Ethyl-6-methylphenyl)-2-methyl-5-phenyl-1,3-thiazolium-4-
olate (12a) and 3-(2-Ethyl-6-methylphenyl)-2-methylidene-5-phenyl-
1,3-thiazolidin-4-one (12b): Diethyl ether was added to the CH2Cl2
solution resulting from thioamide 7 to give crystals of 12a and 12b
(4.0 mmol, 60%); m.p. 107.1 °C (dec.). IR (CDCl3, solution):
ν˜max ϭ 1710, 1629 cmϪ1. Alternatively, diethyl ether was added
to the CH2Cl2 solution resulting from thioamide 7 until incipient
precipitation and the mixture was kept at Ϫ20 °C, yellow crystals
of 12b (cis/trans) thus being obtained (1.3 mmol, 20%). IR (KBr):
ν˜max ϭ 1697, 1601 cmϪ1 1H NMR (400 MHz, CDCl3) (cis-12b):
.
(BARϩ): calcd. for C18H18ClNOS
ϩ
Hϩ 332.08759; found
δ ϭ 7.53Ϫ7.12 (m, 10 H, ArH, cis-12b, trans-12b), 5.28 (s, 1 H,
CH, cis-12b), 5.26 (s, 1 H, CH, trans-12b), 4.33 (d, J ϭ 2.9 Hz, 1
H, C-2ϭCHaHb, cis-12b), 4.32 (d, J ϭ 2.8 Hz, 1 H, C-2ϭCHaHb,
trans-12b), 4.04 (d, J ϭ 2.9 Hz, 1 H, C-2ϭCHaHb, cis-12b, trans-
12b), 2.50 (dq, 2 H, J ϭ 7.4 Hz, ArCH2CH3, cis-12b), 2.44 (q, J ϭ
7.4 Hz, 2 H, ArCH2CH3, trans-12b), 2.17 (s, 3 H, ArCH3, trans-
12b), 2.11 (s, 3 H, ArCH3, cis-12b), 1.21 (t, J ϭ 7.5 Hz, 3 H,
ArCH2CH3, cis-12b), 1.07 (t, J ϭ 7.5 Hz, 3 H, ArCH2CH3, trans-
332.090286; ∆ ϭ Ϫ8.1 ppm.
Acknowledgments
This work was supported by the Spanish Ministry of Science and
Technology (Grants BQU2000-0248, BQU2002-00015 and
BQU2003-05946). J. D. thanks the Ministry of Education for a pre-
doctoral scholarship.
1
12b) ppm. H NMR (400 MHz, CDCl3) (12a): δ ϭ 7.53Ϫ7.12 (m,
9 H, ArH), 7.91 (d, J ϭ 7.0 Hz, 1 H, ArH), 2.53Ϫ2.40 (q, J ϭ
7.52 Hz, 2 H, ArCH2CH3), 2.36 (s, 3 H, C-2ϪCH3), 2.08 (s, 3 H,
ArCH3), 1.25Ϫ1.16 (t, J ϭ 7.6 Hz, 3 H, ArCH2CH3) ppm. 13C
NMR (100 MHz, CDCl3): δ ϭ 171.0, 170.9 (C-4, 12a, 12b), 159.2
(C-4, 12a), 142.3, 139.6, 139.6, 137.2, 136.6, 132.4, 130.1, 129.5,
128.9, 128.6, 128.5, 128.4, 128.3, 127.0, 123.4 (ArC, ArN, C-2, 12a,
12b), 85.4 (C-2ϭCH2, 12b), 51.5 (C-5, 12b), 24.1, 24.0, 23.8
(ArCH2CH3, 12a, 12b), 17.6, 17.5, 17.4, 17.0 (C-2ϪCH3, 12a,
[1] [1a]
C. G. Newton, C. A. Ramsden, Tetrahedron 1982, 38,
[1b]
2965Ϫ3011.
H. L. Gingrich, J. S. Baum, The Chemistry of
Heterocyclic Compounds, vol. 45 (‘‘Oxazoles’’) (Ed.: I. J. Tur-
chi), Wiley, New York, 1986, pp. 731Ϫ961.
[2] [2a]
K. T. Potts, 1,3-Dipolar Cycloaddition Chemistry (Ed.: A.
Padwa), Wiley-Interscience, New York, 1984, vol. 2, pp. 1Ϫ82.
[2b]
A. M. Schoffstall, A. Padwa, Advances in Cycloaddition
(Ed.: D. P. Curran), JAI Press Inc., Greenwich, CT, 1990, vol.
2810
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2004, 2805Ϫ2811